Synthesis of two isotopically labeled versions of NEDD8-activating enzyme (NAE) inhibitor

被引:5
|
作者
Li, Yuexian [1 ]
Plesescu, Mihaela [1 ]
Prakash, Shimoga R. [1 ]
机构
[1] Millennium Pharmaceut Inc, Dept Drug Metab & Phannacokinet, Isotope Chem Grp, Cambridge, MA 02139 USA
关键词
NAE inhibitor; MLN4924; (14)C-6-chloro-7-deazapurine D(8)-(S)-1-aminoindan;
D O I
10.1016/j.tetlet.2011.02.033
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
The synthesis of two isotopically labeled versions of an investigational NAE inhibitor (MLN4924) is reported. (14)C-MLN4924 was synthesized from (14)C-thiourea in eight steps. D(8)-MLN4924 was prepared from D(9)-3-phenylpropanoic acid in seven steps. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1807 / 1810
页数:4
相关论文
共 50 条
  • [11] Antitumor activity of MLN4924, an investigational inhibitor of NEDD8-activating enzyme (NAE), in preclinical models of melanoma.
    Traore, T.
    Mihollen, M.
    Garnsey, J.
    Berger, A.
    Manfredi, M.
    Cosmopolous, K.
    Donelan, J.
    Smith, P. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [12] TRAF2 Regulates Hepatocellular Carcinogenesis Via Modulating the Activity of NEDD8-Activating Enzyme (NAE)
    Liang, Xue
    Yao, Jiping
    Zhao, Yongchao
    Zheng, Min
    HEPATOLOGY, 2018, 68 : 881A - 881A
  • [13] SYNTHESIS OF TWO ISOTOPICALLY LABELED VERSIONS OF AURORA A KINASE INHIBITOR
    Li, Yuexian
    Prakash, Shimoga R.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2010, 53 (5-6): : 448 - 450
  • [14] Discovery of deoxyvasicinone derivatives as inhibitors of NEDD8-activating enzyme
    Zhong, Hai-Jing
    Leung, Ka-Ho
    Lin, Sheng
    Chan, Daniel Shiu-Hin
    Han, Quan-Bin
    Chan, Sharon Lai-Fung
    Ma, Dik-Lung
    Leung, Chung-Hang
    METHODS, 2015, 71 : 71 - 76
  • [15] MLN4924, an investigational NEDD8-activating enzyme (NAE) inhibitor, in patients (pts) with metastatic melanoma: Results of a phase I study.
    Bhatia, S.
    Hamid, O.
    Pavlick, A. C.
    Mulligan, G.
    Smith, P. G.
    Pickard, M. D.
    Shultz, M.
    Walker, R. M.
    Dezube, B.
    O'Day, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [16] Mechanistic RBC Partitioning Studies of MLN4924, a Nedd8-Activating Enzyme inhibitor
    Xia, Cindy Q.
    Chen, Susan
    Zhang, Ji
    Wu, Jing-Tao
    Qian, Mark G.
    Lee, Frank W.
    Balani, Suresh K.
    DRUG METABOLISM REVIEWS, 2010, 42 : 94 - 95
  • [17] AKT inhibitor MK-2206 sensitizes breast cancer cells to MLN4924, a first-in-class NEDD8-activating enzyme (NAE) inhibitor
    Chen, Xiaoyu
    Cui, Danrui
    Bi, Yanli
    Shu, Jianfeng
    Xiong, Xiufang
    Zhao, Yongchao
    CELL CYCLE, 2018, 17 (16) : 2069 - 2079
  • [18] Structure-based identification of a NEDD8-activating enzyme inhibitor via drug repurposing
    Wu, Ke-Jia
    Zhong, Hai-Jing
    Li, Guodong
    Liu, Chenfu
    Wang, Hui-Min David
    Ma, Dik-Lung
    Leung, Chung-Hang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 143 : 1021 - 1027
  • [19] Oncolytic virus and inhibitor for NEDD8-activating enzyme pevonedistat: Promising combination for cancer therapy?
    Guo, Zong Sheng
    MOLECULAR THERAPY, 2023, 31 (11) : 3112 - 3114
  • [20] PEVONEDISTAT, A FIRST-IN-CLASS NEDD8-ACTIVATING ENZYME INHIBITOR, IS A POTENT INHIBITOR OF HEPATITIS B VIRUS
    Sekiba, Kazuma
    Otsuka, Motoyuki
    Koike, Kazuhiko
    GASTROENTEROLOGY, 2019, 156 (06) : S1194 - S1194